• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Comparison of Apixaban Versus Enoxaparin for Venous Thromboembolism Prevention After Radical Cystectomy: The CARE Trial.

作者信息

Michel Katharine F, Slinger Michelle, Stambakio Hanna, Talwar Ruchika, Luckenbough Amy N, Kates Max, Patel Sunil H, Keele Luke J, Bivalacqua Trinity J

机构信息

Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Drexel University College of Medicine, Philadelphia, PA, USA.

出版信息

Eur Urol Focus. 2024 Oct 22. doi: 10.1016/j.euf.2024.10.002.

DOI:10.1016/j.euf.2024.10.002
PMID:39443196
Abstract

CARE is a pragmatic randomized clinical trial designed to compare adherence, satisfaction, patient out-of-pocket costs, and venous thromboembolism (VTE) rates between apixaban and enoxaparin prescribed as VTE prophylaxis on discharge after radical cystectomy.

摘要

相似文献

1
Comparison of Apixaban Versus Enoxaparin for Venous Thromboembolism Prevention After Radical Cystectomy: The CARE Trial.
Eur Urol Focus. 2024 Oct 22. doi: 10.1016/j.euf.2024.10.002.
2
Outcomes from a prospectively implemented protocol using apixaban after robot-assisted radical cystectomy.机器人辅助根治性膀胱切除术后应用阿哌沙班的前瞻性实施方案的结果。
BJU Int. 2023 Oct;132(4):390-396. doi: 10.1111/bju.16036. Epub 2023 May 11.
3
[Budgetary impact for the National Health System of apixaban prophylaxis of venous thromboembolism in patients undergoing total knee or hip replacement].[阿哌沙班预防全膝关节或全髋关节置换术患者静脉血栓栓塞对国家卫生系统的预算影响]
Rev Esp Salud Publica. 2012 Dec;86(6):601-12. doi: 10.4321/S1135-57272012000600006.
4
Practice patterns for extended venous thromboembolism chemoprophylaxis among urologic oncologists after radical cystectomy.根治性膀胱切除术后泌尿外科肿瘤学家进行延长静脉血栓栓塞化学预防的实践模式。
Urol Oncol. 2020 Nov;38(11):849.e19-849.e23. doi: 10.1016/j.urolonc.2020.05.030. Epub 2020 Jun 29.
5
Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous Heparin.与仅住院皮下肝素相比,延长依诺肝素持续时间可降低根治性膀胱切除术后静脉血栓栓塞事件的发生率。
J Urol. 2017 Feb;197(2):302-307. doi: 10.1016/j.juro.2016.08.090. Epub 2016 Aug 26.
6
Rethinking the one-size-fits-most approach to venous thromboembolism prophylaxis after radical cystectomy.重新思考根治性膀胱切除术后采用一刀切的方法预防静脉血栓栓塞症。
Urol Oncol. 2020 Oct;38(10):797.e1-797.e6. doi: 10.1016/j.urolonc.2020.05.007. Epub 2020 Jul 3.
7
Efficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center.在综合性癌症中心行开腹妇科癌症手术后,阿哌沙班用于预防术后静脉血栓栓塞症的疗效、安全性和可行性。
Gynecol Oncol. 2024 Apr;183:120-125. doi: 10.1016/j.ygyno.2024.01.039. Epub 2024 Feb 16.
8
A Canadian study of the cost-effectiveness of apixaban compared with enoxaparin for post-surgical venous thromboembolism prevention.一项比较阿哌沙班与依诺肝素用于术后静脉血栓栓塞预防的成本效益的加拿大研究。
Postgrad Med. 2013 Jul;125(4):141-53. doi: 10.3810/pgm.2013.07.2686.
9
Implementation of a Perioperative Venous Thromboembolism Prophylaxis Program for Patients Undergoing Radical Cystectomy on an Enhanced Recovery After Surgery Protocol.在加速康复外科方案下接受根治性膀胱切除术患者的围手术期静脉血栓栓塞症预防方案的实施。
Eur Urol Focus. 2020 Jan 15;6(1):74-80. doi: 10.1016/j.euf.2018.08.025. Epub 2018 Sep 15.
10
Extended Anticoagulation after Radical Cystectomy Using Direct Acting Oral Anticoagulants: A Single-Institutional Experience.根治性膀胱切除术后使用直接口服抗凝剂延长抗凝治疗:单机构经验。
Urol Pract. 2022 Sep;9(5):451-458. doi: 10.1097/UPJ.0000000000000330. Epub 2022 Jul 5.

引用本文的文献

1
Comparative analysis of apixaban vs. enoxaparin for thromboprophylaxis after radical cystectomy A single-center, observational, before-after study.阿哌沙班与依诺肝素用于根治性膀胱切除术后血栓预防的比较分析:一项单中心、观察性、前后对照研究。
Can Urol Assoc J. 2025 Aug;19(8):236-241. doi: 10.5489/cuaj.9312.